The review synthesizes evidence on whether Alzheimer’s disease medications can improve neurocognitive outcomes in children ...

New research shows GRIN2A may be the first single gene capable of causing mental illness, challenging long-held beliefs about ...

The surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric ...

The shadow of Alzheimer's disease looms large over our aging population. It is more than a memory disorder; it's a humanitarian, social, and economic crisis. Accounting for nearly 80 percent of all ...

Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

Axsome Therapeutics, Inc. remains a Sell due to an undifferentiated CNS pipeline, heavy SG&A and net losses. Learn more about ...

Walking thousands of steps each day might be one of the most powerful weapons against Alzheimer’s disease, according to groundbreaking new research that tracked nearly 300 older adults for more than a ...

Total 3Q 2025 net product revenue of $171.0 million, representing 63% year-over-year growthAUVELITY® 3Q 2025 net product sales of $136.1 million, ...

WILMINGTON, N.C. (WECT) - Neighbors are making their steps count for a good cause in Wilmington. The Eastern North Carolina Chapter of Alzheimer’s Association held their annual fundraiser on UNCW’s ...

On a crisp golden fall afternoon ‒ right before Vermont turned into stick season ‒ we were tootling around Morrisville. My husband, Charlie, was feeling a little low. He lives with early onset ...